Overview

Two-period 21 Day Cross-over Study to Compare the Pharmacokinetics of Tiotropium From Two Inhalers

Status:
Completed
Trial end date:
2018-05-03
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the absorption of a test inhalation product with the reference product in healthy volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
3M
Collaborator:
Simbec Research
Treatments:
Tiotropium Bromide